Abstract
Safety and Effectiveness of Idelalisib in Patients with Double-Refractory Follicular Lymphoma: A Pan-European Cohort of 242 Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood-2021-146066
Copy DOIJournal: Blood | Publication Date: Nov 5, 2021 |
Safety and Effectiveness of Idelalisib in Patients with Double-Refractory Follicular Lymphoma: A Pan-European Cohort of 242 Patients
Join us for a 30 min session where you can share your feedback and ask us any queries you have